Study results indicate that the latest-generation design of Bioventus’ EXOGEN® Ultrasound Bone Healing System improves patient compliance by 10%, with overall compliance at a minimum of 76%. The device employs low-intensity pulsed ultrasound to help stimulate the natural healing process.
The next-generation device, which launched in 2014, features a compliance calendar. Among 12,984 patient data files analyzed, compliance was 84% vs. a rate of 74% with the previous model. Further, incorporation of the calendar resulted in compliance never decreasing below 76% over the 6-month analysis.
Researchers also analyzed 12 clinical trials on the ultrasound technology for which compliance was recorded. In eight of these studies that met endpoints, compliance was 88%. If the primary endpoint was unmet, compliance averaged 54%.
Study results indicate that the latest-generation design of Bioventus' EXOGEN® Ultrasound Bone Healing System improves patient compliance by 10%, with overall compliance at a minimum of 76%. The device employs low-intensity pulsed ultrasound to help stimulate the natural healing process.
The next-generation device, which launched in 2014,...
Study results indicate that the latest-generation design of Bioventus’ EXOGEN® Ultrasound Bone Healing System improves patient compliance by 10%, with overall compliance at a minimum of 76%. The device employs low-intensity pulsed ultrasound to help stimulate the natural healing process.
The next-generation device, which launched in 2014, features a compliance calendar. Among 12,984 patient data files analyzed, compliance was 84% vs. a rate of 74% with the previous model. Further, incorporation of the calendar resulted in compliance never decreasing below 76% over the 6-month analysis.
Researchers also analyzed 12 clinical trials on the ultrasound technology for which compliance was recorded. In eight of these studies that met endpoints, compliance was 88%. If the primary endpoint was unmet, compliance averaged 54%.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
